Pfizer

COVID-19: US Expert Panel Approves Emergency Use Of Pfizer Vaccine

Washington: An expert committee convened by the US Food and Drug Administration (FDA) has voted heavily in favour of recommending…

December 11, 2020

Vaccine To Be Priced As Per Country’s GDP: Pfizer

New York: Pfizer has decided to keep a differential pricing on its COVID-19 vaccine, which will be based on a…

December 10, 2020

COVID-19 Vaccine: Four Pfizer Volunteers Develop Temporary Facial Paralysis

New York: The US Food and Drug Administration (FDA) has revealed that the COVID-19 vaccine developed by Pfizer-BioNTech saw four…

December 10, 2020

Pfizer Vaccine Leads To Allergic Reactions In 2 People; Warning Issued

London: Regulators have added allergic reaction warnings for Pfizer's COVID-19 vaccine. Anyone with a history of significant allergic reactions are…

December 9, 2020

Know The First Indian-Origin Recipients Of COVID-19 Vaccine In UK

London:  Dr Hari Shukla, 87 and his wife Ranjan, 83-year-old wife from the northeast of England on Tuesday became the…

December 9, 2020

After Pfizer & SII, Bharat Biotech Too Seeks Emergency Use Approval For Covaxin

Hyderabad: Pfizer and the Serum Institute of India (SII) had already sought emergency use approval for their COVID-19 vaccines from…

December 8, 2020

COVID-19 Vaccine: Serum Institute Seeks Emergency Use Approval

New Delhi: The Serum Institute of India (SII) has sought emergency use authorisation of its vaccine candidate Covishield in the…

December 7, 2020

Now, Results Show Oxford-AstraZeneca COVID-19 Vaccine Can Be 90% Effective

London: The frontrunners in the race to develop a coronavirus vaccine continue to show positive results. After Pfizer and Moderna…

November 23, 2020

Pfizer-BioNTech Vaccine Could Be Delivered Next Month

New York: Pfizer Inc PFE.N and BioNTech 22UAy.DE could get emergency US and European approval for their COVID-19 vaccine in…

November 19, 2020

Pfizer’s COVID Vaccine 95% Effective With No Major Side Effects; Transportation A Concern

London: Pharma major Pfizer on Wednesday reported that its COVID-19 vaccine is 95 per cent effective in phase 3 trials…

November 18, 2020